News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Novartis International AG Diabetes Drug Galvus Approved in Europe
September 28, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Sept 28 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research) potential blockbuster diabetes treatment Galvus has been approved for use in the European Union, the Swiss drugmaker said on Friday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
Policy
Former CBER Chief Marks Decries New FDA COVID-19 Framework
June 26, 2025
·
3 min read
·
Tristan Manalac
Duchenne muscular dystrophy
FDA Reviews Sarepta’s Elevidys After Second Patient Death
June 25, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
·
2 min read
·
Tristan Manalac
Podcast
FDA Churn Continues, RFK Faces Congress, Obesity Insights at ADA, BIO2025 Recap
June 25, 2025
·
2 min read
·
Heather McKenzie
